Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CHEMCON.NS Stock Summary
Top 10 Correlated ETFs
CHEMCON.NS
In the News
CHEMCON.NS Financial details
Company Rating
Buy
Market Cap
9.27B
Income
267.6M
Revenue
2.87B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
204
Optionable
No
Shortable
Yes
Earnings
24 May 2024
P/E
31.1
Forward P/E
-
PEG
-5.41
P/S
3.38
P/B
2.23
P/C
-
P/FCF
-
Quick Ratio
3.48
Current Ratio
5.01
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
7.29
EPS next Y
-
EPS next Q
-
EPS this Y
-12.2%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
5.06%
Revenue last 5Y
0.01%
Revenue Q/Q
-29.54%
EPS Q/Q
-25.31%
-
-
-
-
SMA20
-6.79%
SMA50
-13.64%
SMA100
-6.08%
Inst Own
-
Inst Trans
-
ROA
6%
ROE
15%
ROC
0.09%
Gross Margin
30%
Oper. Margin
14%
Profit Margin
11%
Payout
-
Shs Outstand
36.63M
Shs Float
9.36M
-
-
-
-
Target Price
-
52W Range
221.0-319.45
52W High
-27.59%
52W Low
+4.52%
RSI
30
Rel Volume
1.27
Avg Volume
111.79K
Volume
142.48K
Perf Week
-10.12%
Perf Month
-14.01%
Perf Quarter
-16.61%
Perf Half Y
-18.46%
-
-
-
-
Beta
-0.337
-
-
Volatility
7.65%, 11.85%
Prev Close
-2.63%
Price
231
Change
-4.94%
CHEMCON.NS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 82.63 | 71.32 | 71.07 | 70.09 | 82.69 | |
Net income per share | 11.75 | 13.34 | 16.48 | 17.13 | 15.04 | |
Operating cash flow per share | 3.02 | 2.87 | 19 | 20.26 | 3.48 | |
Free cash flow per share | -0.88 | -1.65 | 9.69 | 6.59 | -9.13 | |
Cash per share | 0.19 | 0.29 | 14.96 | 30.7 | 36.9 | |
Book value per share | 26.49 | 39.96 | 103.35 | 113.89 | 124.86 | |
Tangible book value per share | 26.48 | 39.95 | 103.34 | 113.88 | 124.85 | |
Share holders equity per share | 26.49 | 39.96 | 103.35 | 113.89 | 124.86 | |
Interest debt per share | 9.82 | 13.41 | 2.85 | 9.98 | 17.88 | |
Market cap | 21.42B | 21.42B | 13.95B | 9.77B | 8.38B | |
Enterprise value | 21.75B | 21.87B | 13.77B | 9.77B | 8.58B | |
P/E ratio | 49.77 | 43.85 | 24.73 | 15.56 | 15.21 | |
Price to sales ratio | 7.08 | 8.2 | 5.73 | 3.8 | 2.77 | |
POCF ratio | 193.72 | 203.98 | 21.45 | 13.16 | 65.77 | |
PFCF ratio | -666.3 | -353.49 | 42.05 | 40.47 | -25.05 | |
P/B Ratio | 22.08 | 14.64 | 3.94 | 2.34 | 1.83 | |
PTB ratio | 22.08 | 14.64 | 3.94 | 2.34 | 1.83 | |
EV to sales | 7.18 | 8.37 | 5.66 | 3.81 | 2.83 | |
Enterprise value over EBITDA | 32.47 | 29.84 | 15.95 | 10.67 | 10.21 | |
EV to operating cash flow | 196.65 | 208.23 | 21.17 | 13.16 | 67.31 | |
EV to free cash flow | -676.39 | -360.86 | 41.5 | 40.48 | -25.64 | |
Earnings yield | 0.02 | 0.02 | 0.04 | 0.06 | 0.07 | |
Free cash flow yield | 0 | 0 | 0.02 | 0.02 | -0.04 | |
Debt to equity | 0.34 | 0.31 | 0.02 | 0.09 | 0.14 | |
Debt to assets | 0.19 | 0.2 | 0.02 | 0.07 | 0.12 | |
Net debt to EBITDA | 0.48 | 0.61 | -0.21 | 0 | 0.23 | |
Current ratio | 1.86 | 2.8 | 6.3 | 4.84 | 3.41 | |
Interest coverage | 22.08 | 19.5 | 21.4 | 140.85 | 41.88 | |
Income quality | 0.18 | 0.16 | 0.86 | 0.88 | 0.17 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0.02 | |
Payout ratio | 0 | 0 | 0 | 0 | 0.27 | |
Sales general and administrative to revenue | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -1.29 | -1.58 | -0.49 | -0.67 | -3.63 | |
Capex to revenue | -0.05 | -0.06 | -0.13 | -0.2 | -0.15 | |
Capex to depreciation | -4.98 | -3.59 | -5.24 | -7.99 | -5.52 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 83.68 | 109.5 | 195.75 | 209.52 | 205.58 | |
ROIC | 0.34 | 0.26 | 0.16 | 0.13 | 0.09 | |
Return on tangible assets | 0.25 | 0.22 | 0.14 | 0.13 | 0.1 | |
Graham Net | 2.75 | 9.68 | 46.25 | 60.12 | 36.37 | |
Working capital | 604.79M | 1.11B | 2.39B | 2.98B | 2.2B | |
Tangible asset value | 970.04M | 1.46B | 3.54B | 4.17B | 4.57B | |
Net current asset value | 550.88M | 931.38M | 2.35B | 2.95B | 2.15B | |
Invested capital | 0.34 | 0.31 | 0.02 | 0.09 | 0.14 | |
Average receivables | 633.77M | 1.01B | 1.45B | 1.99B | 1.51B | |
Average payables | 230.75M | 272.97M | 241.54M | 232.3M | 226.25M | |
Average inventory | 334.75M | 469.95M | 535.23M | 467.97M | 568.34M | |
Days sales outstanding | 100.38 | 167.22 | 255.1 | 324.61 | 87.65 | |
Days payables outstanding | 51.3 | 56.17 | 61.34 | 62.39 | 44.39 | |
Days of inventory on hand | 81.58 | 104.99 | 160.16 | 90.49 | 164.17 | |
Receivables turnover | 3.64 | 2.18 | 1.43 | 1.12 | 4.16 | |
Payables turnover | 7.12 | 6.5 | 5.95 | 5.85 | 8.22 | |
Inventory turnover | 4.47 | 3.48 | 2.28 | 4.03 | 2.22 | |
ROE | 0.44 | 0.33 | 0.16 | 0.15 | 0.12 | |
Capex per share | -3.9 | -4.52 | -9.31 | -13.67 | -12.61 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 20.88 | 21.59 | 21.66 | 20.53 | 14.46 | |
Net income per share | 3.1 | 2.86 | 1.61 | 1.62 | 1.21 | |
Operating cash flow per share | 1.17 | 1.23 | 1.43 | 1.42 | 1.41 | |
Free cash flow per share | 1.17 | 1.23 | 1.43 | 1.42 | 1.41 | |
Cash per share | 53.09 | 36.9 | 35.71 | 39.1 | 0 | |
Book value per share | 118.94 | 124.86 | 124.86 | 128.06 | 0 | |
Tangible book value per share | 0 | 124.85 | 0 | 128.06 | 0 | |
Share holders equity per share | 118.94 | 124.86 | 124.86 | 128.06 | 0 | |
Interest debt per share | 0.16 | 17.61 | 0.18 | 10.93 | 0.28 | |
Market cap | 10.95B | 8.38B | 10.17B | 10.31B | 10.85B | |
Enterprise value | 12.89B | 8.58B | 11.48B | 10.69B | 10.85B | |
P/E ratio | 24.1 | 20.01 | 43.04 | 43.41 | 61.06 | |
Price to sales ratio | 14.32 | 10.6 | 12.82 | 13.71 | 20.48 | |
POCF ratio | 256.28 | 185.81 | 194.04 | 198.73 | 210.4 | |
PFCF ratio | 256.28 | 185.81 | 194.04 | 198.73 | 210.4 | |
P/B Ratio | 2.51 | 1.83 | 2.22 | 2.2 | 0 | |
PTB ratio | 2.51 | 1.83 | 2.22 | 2.2 | 0 | |
EV to sales | 16.86 | 10.85 | 14.47 | 14.22 | 20.48 | |
Enterprise value over EBITDA | 71.84 | 50.6 | 101.59 | 94.13 | 171.15 | |
EV to operating cash flow | 301.8 | 190.15 | 218.99 | 206.04 | 210.4 | |
EV to free cash flow | 301.8 | 190.15 | 218.99 | 206.04 | 210.4 | |
Earnings yield | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Free cash flow yield | 0 | 0.01 | 0.01 | 0.01 | 0 | |
Debt to equity | 0 | 0.14 | 0 | 0.08 | 0 | |
Debt to assets | 0 | 0.12 | 0 | 0.07 | 0 | |
Net debt to EBITDA | 10.83 | 1.15 | 11.58 | 3.34 | 0 | |
Current ratio | 0 | 3.41 | 0 | 5.01 | 0 | |
Interest coverage | 26.83 | 30.09 | 7.52 | 12.08 | 3.61 | |
Income quality | 0.38 | 0.43 | 0.89 | 0.87 | 1.16 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 91.1 | 89.61 | 67.31 | 68.34 | 0 | |
ROIC | 0.03 | 0.02 | 0.01 | 0.01 | 0 | |
Return on tangible assets | 0 | 0.02 | 0 | 0.01 | 0 | |
Graham Net | 53.09 | 36.37 | 35.71 | 49.3 | 0 | |
Working capital | 1.94B | 2.2B | 1.31B | 2.7B | 0 | |
Tangible asset value | 0 | 4.57B | 0 | 4.69B | 0 | |
Net current asset value | 1.94B | 2.15B | 1.31B | 2.66B | 0 | |
Invested capital | 0 | 0.14 | 0 | 0.08 | 0 | |
Average receivables | 403.76M | 363.65M | 363.65M | 457.38M | 457.38M | |
Average payables | 89.17M | 106.88M | 106.88M | 88.55M | 88.55M | |
Average inventory | 354.31M | 395.23M | 395.23M | 406.55M | 406.55M | |
Days sales outstanding | 0 | 82.77 | 0 | 109.49 | 0 | |
Days payables outstanding | 0 | 35.9 | 0 | 29.82 | 0 | |
Days of inventory on hand | 0 | 132.75 | 0 | 136.9 | 0 | |
Receivables turnover | 0 | 1.09 | 0 | 0.82 | 0 | |
Payables turnover | 0 | 2.51 | 0 | 3.02 | 0 | |
Inventory turnover | 0 | 0.68 | 0 | 0.66 | 0 | |
ROE | 0.03 | 0.02 | 0.01 | 0.01 | 0 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CHEMCON.NS Frequently Asked Questions
What is Chemcon Speciality Chemicals Limited stock symbol ?
Chemcon Speciality Chemicals Limited is a IN stock and trading under the symbol CHEMCON.NS
What is Chemcon Speciality Chemicals Limited stock quote today ?
Chemcon Speciality Chemicals Limited stock price is $231 today.
Is Chemcon Speciality Chemicals Limited stock public?
Yes, Chemcon Speciality Chemicals Limited is a publicly traded company.